Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Prescription Drug Abuse
Interventions: MyHealthyChoices, Health Risk Assessment; Behavioral · Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Baltimore, Maryland • Morgantown, West Virginia

Conditions: Presbyopia
Interventions: 0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo; Drug
Lead sponsor: Santen Inc.; Industry
Eligibility: 47 Years to 55 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 12
States / cities: Glendale, California • Newport Beach, California • Morrow, Georgia + 9 more

Conditions: Children/Youth With Special Healthcare Needs, Adults With Multiple Chronic Conditions
Interventions: Caremap app; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Alzheimer's Disease
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 55 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2006
U.S. locations: 2
States / cities: Baltimore, Maryland • Bethesda, Maryland

Conditions: Anal Canal Squamous Cell Carcinoma, Stage I Anal Cancer AJCC v8, Stage II Anal Cancer AJCC v8, Stage IIA Anal Cancer AJCC v8, Stage IIB Anal Cancer AJCC v8, Stage III Anal Cancer AJCC v8, Stage IIIA Anal Cancer AJCC v8, Stage IIIB Anal Cancer AJCC v8, Stage IIIC Anal Cancer AJCC v8
Interventions: Cisplatin, Fluorouracil, Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy, Quality-of-Life Assessment, Questionnaire Administration; Drug · Radiation · Procedure + 1 more
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Fibromyalgia
Interventions: TNX-102 SL, Placebo SL Tablet; Drug
Lead sponsor: Tonix Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 514 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 36
States / cities: Birmingham, Alabama • Phoenix, Arizona • Oceanside, California + 33 more

Conditions: Dry Eye, Contact Lens Complication
Interventions: Systane Complete, Sensitive Eyes Rewetting Drops; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 3
States / cities: Birmingham, Alabama • Babylon, New York • Memphis, Tennessee

Conditions: Pulmonary Embolism, Deep Vein Thrombosis, Atrial Fibrillation
Interventions: Warfarin; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 344 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Basal Cell Carcinoma, Squamous Cell Carcinoma, Skin Cancer, Anxiety
Interventions: Randomized Midazolam, Placebo, Local Anesthesia, Prospective Midazolam; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: HIV Infections
Interventions: Zidovudine, Didanosine; Drug
Lead sponsor: Glaxo Wellcome; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 4
States / cities: San Francisco, California • Miami, Florida • Boston, Massachusetts + 1 more

Conditions: Chronic Hepatitis B
Interventions: Not listed
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Foster City, California

Conditions: Cystic Fibrosis
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 12 Years and older
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Children, Only, Tonsillar Hypertrophy, Adenoid Hypertrophy
Interventions: Lidocaine Iv, Saline Solution; Drug
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 4 Years to 10 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Apraxia of Speech, Aphasia, Cerebrovascular Accident
Interventions: Normal Auditory Feedback, Masked Auditory Feedback, Altered Auditory Feedback; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Chronic Lymphocytic Leukemia, B-Cell Lymphoma
Interventions: DTRMWXHS-12, DTRM-505, DTRM-555; Drug
Lead sponsor: Zhejiang DTRM Biopharma; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 6
States / cities: Phoenix, Arizona • New Haven, Connecticut • Jacksonville, Florida + 3 more

Conditions: Healthy Subject
Interventions: Best Practice, Informational Intervention, Questionnaire Administration, Text Message-Based Intervention; Other · Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years to 25 Years · Male only
Enrollment: 1,227 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Columbus, Ohio

Conditions: Pain, Intractable
Interventions: pain blocking; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Irvine, California

Conditions: Opioid-Related Disorders
Interventions: Buprenorphine; Drug
Lead sponsor: Yale University; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1988 – 2006
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Blood Pressure
Interventions: Ambulatory (24-hour) Blood Pressure; Device
Lead sponsor: University of Texas at Austin; Other
Eligibility: 30 Years to 60 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Constipation
Interventions: RM-131, Placebo; Drug
Lead sponsor: Motus Therapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Preventive Screening, Prostate Cancer, Osteoporosis, Colorectal Cancer
Interventions: Quantitative Information Sheet, Qualitative Information Sheet, Narrative Information Sheet, Framed Information Sheet; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 85 Years
Enrollment: 775 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: HIV, Hepatitis C, Hepatitis B, Syphilis
Interventions: Rapid tests for HIV, HCV, HBV, and syphilis, HIV/HCV, HIV/syphilis, HIV only; Device
Lead sponsor: California State University, Long Beach; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Cardiovascular Diseases
Interventions: Point of Care, Population Management; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 5
States / cities: Chicago, Illinois • DeKalb, Illinois • Oak Brook, Illinois + 2 more

Conditions: Multiple Sclerosis
Interventions: Constraint-Induced Movement Therapy; Behavioral
Lead sponsor: National Multiple Sclerosis Society; Other
Eligibility: 21 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Using m-Health Tools to Reduce the Misuse of Opioid Pain Relievers

Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia

Caremap: A Digital Personal Health Record for Complex Care Coordination

MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia

Direct Application of Systane Complete to Contact Lenses

Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information

Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery

A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)

Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.

HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy

Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy

Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

HPV Vaccine Intervention for Young Sexual Minority Men

Pain Blocking During Drug Administration or Blood Collection With Needles

Buprenorphine Maintenance for Opioid Addicts - 3

24-hour Blood Pressure Measurements and Ischemic Conditioning

Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation

Understanding and Discouraging Overuse of Potentially Harmful Screening Tests

Behavioral Science Aspects of Rapid Test Acceptance

Healthy Hearts in the Heartland

Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)